DLG2 Mutations in the Etiology of Pubertal Delay and Idiopathic Hypogonadotropic Hypogonadism.


Journal

Hormone research in paediatrics
ISSN: 1663-2826
Titre abrégé: Horm Res Paediatr
Pays: Switzerland
ID NLM: 101525157

Informations de publication

Date de publication:
2021
Historique:
received: 29 06 2021
accepted: 22 10 2021
pubmed: 26 10 2021
medline: 5 4 2022
entrez: 25 10 2021
Statut: ppublish

Résumé

Idiopathic hypogonadotropic hypogonadism (IHH) is caused by dysfunction of the hypothalamic-pituitary-gonadal axis. DLG2 was recently implicated as a gene associated with delayed puberty and which may also contribute to IHH. The confirmation of the candidate puberty genes in independent IHH cohorts has become crucial due to the lack of proper genotype-phenotype segregations in reported pedigrees. Therefore, we aimed to screen DLG2 in patient variants in a large cohort of IHH patients. The present study included a total of 336 IHH patients from 290 independent families. The coding and flanking regions of DLG2 were screened for potentially important variants in the WES data. Candidate variants were evaluated in the -gnomAD and GME databases according to their allele frequencies, and only those with a frequency <0.0001 were considered rare. Detected variants were classified according to the ACMG/AMP criteria. We found 1 homozygous and 2 heterozygous missense variants in 3 independent pedigrees. Identified variants were found extremely rare or not reported in gnomAD. Two variants were categorized as "uncertain significance," and the other one was "likely pathogenic" according to the ACMG criteria. All patients were normosmic, and in 2 of the 3 families, there were no causal variants in other IHH-related genes. We detected 3 rare sequencing variants in DLG2 in 5 patients with IHH or delayed puberty in a large IHH cohort. Our results support the contention that the DLG2 mutations are associated with IHH in human puberty.

Identifiants

pubmed: 34695822
pii: 000520409
doi: 10.1159/000520409
doi:

Substances chimiques

Tumor Suppressor Proteins 0
DLG2 protein, human EC 2.7.4.8
Guanylate Kinases EC 2.7.4.8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

364-368

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Ihsan Turan (I)

Division of Pediatric Endocrinology, Cukurova University, Faculty of Medicine, Adana, Turkey, ihsanturan@hotmail.com.

Korcan Demir (K)

Division of Pediatric Endocrinology, Dokuz Eylul University Faculty of Medicine, İzmir, Turkey.

Eda Mengen (E)

Department of Pediatric Endocrinology, Ankara City Hospital, Ankara, Turkey.

Leman Damla Kotan (LD)

Division of Pediatric Endocrinology, Cukurova University, Faculty of Medicine, Adana, Turkey.

Fatih Gürbüz (F)

Division of Pediatric Endocrinology, Cukurova University, Faculty of Medicine, Adana, Turkey.

Bilgin Yüksel (B)

Division of Pediatric Endocrinology, Cukurova University, Faculty of Medicine, Adana, Turkey.

Ali Kemal Topaloglu (AK)

Department of Neurobiology and Anatomical Sciences, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Division of Pediatric Endocrinology, Department of Pediatrics, University of Mississippi Medical Center, Jackson, Mississippi, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH